Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI

(SAN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sanofi : plans 670 job cuts in France by end 2020

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/05/2018 | 12:09pm EST
The logo of Sanofi is pictured during the Viva Tech start-up and technology summit in Paris

PARIS (Reuters) - French drugmaker Sanofi told unions on Wednesday it was planning to cut 670 jobs in France, a union representative told Reuters.

The plan, which is to be set on a voluntary basis, would affect human resources, IT, and finances among others, Thierry Bodin, with the CGT union said. In addition, 80 IT jobs are to be outsourced, he said.

"This is a terrible loss of expertise. It will have consequences in terms of efficiency," Bodin said.

Sanofi had said in September it would continue to implement cost savings after having reached a 1.5 billion euros (1.34 billion pounds) cost reduction target a year ahead of expectations.

"We are blindsided as Sanofi makes significant amounts of profits. And at a time of strong social tensions in France, the government is looking the other way," Bodin said in reference to the so-called "yellow vest" protests which led to the worst riots seen in central Paris in five decades last Saturday.

A Sanofi spokesman confirmed the company's intention to shed 670 jobs out of a 25,000 workforce in France and said the plan was to be completed by the end of 2020.

At the same time, Sanofi will invest 700 million euros in France to upgrade its production sites, notably in the areas of vaccines manufacturing and other biologic medicines.

(Reporting by Matthias Blamont; Editing by Leigh Thomas and Mathieu Rosemain)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
02/15SANOFI : Iqvia quietly purchased UK-based NLP provider Linguamatics
AQ
02/14SANOFI : Tech startups have two days left to enter the Sanofi Healthcare Innovat..
AQ
02/13SANOFI : PCSK9 price-cut matchup is on, as Regeneron and Sanofi slash Praluent l..
AQ
02/12REGENERON PHARMACEUTICALS : and Sanofi Offer Praluent at a New Reduced U.S. List..
AQ
02/12SANOFI : appoints Ameet Nathwani Chief Digital Officer
GL
02/11Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price
DJ
02/11Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
RE
02/11SANOFI : and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list p..
PR
02/08SANOFI : House panels want raps vs Aquino, Abad, Garin, others over dengue-vacci..
AQ
02/07GLOBAL MARKETS LIVE : General Motors, Sonos, Chipotle Mexican Grill, Publicis ....
More news
Financials (€)
Sales 2019 36 145 M
EBIT 2019 9 294 M
Net income 2019 5 244 M
Debt 2019 15 151 M
Yield 2019 4,15%
P/E ratio 2019 17,28
P/E ratio 2020 15,36
EV / Sales 2019 3,02x
EV / Sales 2020 2,78x
Capitalization 93 861 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 83,4 €
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Ameet Nathwani Executive Vice President-Medical Affairs
John C. Reed Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-0.56%106 006
JOHNSON & JOHNSON4.08%365 768
PFIZER-3.85%245 920
ROCHE HOLDING LTD.11.98%233 242
NOVARTIS7.19%228 685
MERCK AND COMPANY4.45%207 536